Genesis Health
Approved Formulary
Hospital Homepage
Questions about the Formulary?
Click on this link to email us.
Formulary Addition Request
Latex-free Medications -
Username:genesis
Password: latexinfo987
Search by name
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Restricted
PALS Drug Administration Guidelines
Drug Administration Guidelines
Do Not Crush
Black Box Warning
Drug Waste
Webpage Links
Add Formweb to your mobile device
Android
iOS
Home
QuickStart
Admin
Boards
Our Department Mission....Delivering Excellence and Trust in Pharmaceutical Care through a Culture of Precision.
Genesis Health
Approved Formulary
Hospital Homepage
Questions about the Formulary?
Click on this link to email us.
Formulary Addition Request
Latex-free Medications -
Username:genesis
Password: latexinfo987
Search by name
Additional search options
Search by class
Browse alphabetically
Select...
NUM
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
High Alert
Restricted
PALS Drug Administration Guidelines
Drug Administration Guidelines
Do Not Crush
Black Box Warning
Drug Waste
Webpage Links
Search results for:
TAPENTADOL
TAPENTADOL
Drug Name
Form
Strength
Non-Formulary
Notes
NUCYNTA
TABLET
50 mg
NUCYNTA ER
TABLET, EXTENDED RELEASE
50 mg
NUCYNTA ER
TABLET, EXTENDED RELEASE
100 mg
NUCYNTA ER
TABLET, EXTENDED RELEASE
150 mg
NUCYNTA ER
TABLET, EXTENDED RELEASE
200 mg
NUCYNTA ER
TABLET, EXTENDED RELEASE
250 mg
View Other Therapeutic Options:
Opioid Agonists
:
280808
Comments:
If extended-release tablets are crushed or split, a toxic dose may result
Last updated:
May. 21, 2014
Recent Citations via Medline (PubMed)
FDA DRUG INFORMATION
MICROMEDEX
FDA Daily Med Package Inserts
Class II
Add Formweb to your mobile device
If extended-release tablets are crushed or split, a toxic dose may result